IL22 and inflammatory bowel disease: We overexpressed IL‐22 in MSCsBM, which can significantly improve the symptoms of murine experimental IBD model, ameliorate the severity of induced colonic histopathological inflammation and restore the injured gastrointestinal mucosal tissues.